Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · IEX Real-Time Price · USD
21.00
-0.05 (-0.24%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $540.19 million as of July 26, 2024.
Market Cap
540.19M
Enterprise Value
420.04M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $540.19M, an increase of 34.34%. That is a compound annual growth rate of 164.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 541.50M | 34.67% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Canopy Growth | 550.18M |
| Y-mAbs Therapeutics | 546.78M |
| Fulcrum Therapeutics | 543.22M |
| COMPASS Pathways | 539.91M |
| PureTech Health | 538.90M |
| Enhabit | 515.11M |
| Aura Biosciences | 511.78M |
| EyePoint Pharmaceuticals | 506.78M |